Statement on Final 340b Drug Pricing Program Ceiling Price and Civil Monetary Penalties Rule

Tom Nickels
Executive Vice President
American Hospital Association

November 29, 2018


The AHA is pleased that in response to our lawsuit, today’s final rule ensures that the implementation of the long-delayed 340B Drug Pricing Program ceiling price and civil monetary penalties policies will be effective January 1, 2019. Earlier this year, the AHA along with other national organizations representing 340B hospitals, filed a lawsuit to force implementation of this rule in order to shine needed light on drug pricing and to hold price-gouging drug companies accountable. We continue to strongly urge HHS to make available online drug pricing information for 340B hospitals as this rule requires as soon as possible after January 1, and no later than April 1, so that instances of drug company overcharging can be uncovered and penalties enforced.


About the American Hospital Association
The AHA is a not-for-profit association of health care provider organizations and individuals that are committed to the improvement of health in their communities. The AHA is the national advocate for its members, which include nearly 5,000 hospitals, health care systems, networks and other providers of care. Founded in 1898, the AHA provides education for health care leaders and is a source of information on health care issues and trends. For more information, visit https://www.aha.org

 

###

Contact:        

Marie Johnson, (202) 626-2351

Colin Milligan, (202) 638-5491

Related Resources

Legal Documents
The Court determined that the U.S. Department of Health and Human Services ("Agency") acted in an ultra vires fashion when it reduced the payment, in the 2018…
Legal Documents
This Court should reject Defendants’ attempt to re-litigate the merits of the case or, alternatively, to decide on their own if the 340B hospitals are entitled…
Issue Brief
Issue Brief
Issue Brief
Advocacy
The American Hospital Association’s 2019 Public Policy Advocacy Agenda seeks to continue to positively influence the public policy environment for patients,…